Franklin Lakes, NJ, United States of America

Ann Marie Schmidt

This inventor holds 36 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in RAGE Modulators. Top assignees: Columbia University, New York University, The State University of New York. Active years: 1998-2026.

USPTO Granted Patents = 36 (Patent Applications = 14)

% Patents Active = 69.4

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 3.2

ph-index = 13

Forward Citations = 492(Granted Patents)

Location History:

Franklin Lakes, NY (US) (2001)
Franklin Lakes, NJ (US) (1998 - 2023)

Company Filing History:

The State University of New York

patents

4. 2 out of 1,071

The Cleveland Clinic Foundation

patents

5. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Aldose Reductase Inhibitors

RAGE Activity

Diabetes Treatment

Atherosclerosis

Tumor Invasion

Transgenic Mice

Cerebral Blood Flow

Ischemic Disorder

Thrombosis

EN-RAGE

Inflammatory Disorders

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653825 - Aldose reductase inhibitors and uses thereof (2026-06-16),

2. 11730737 - Aldose reductase inhibitors and uses thereof (2023-08-22),

3. 11529349 - Aldose reductase inhibitors and uses thereof (2022-12-20),

4. 11192859 - Quinoline compounds as modulators of RAGE activity and uses thereof (2021-12-07),

5. 10729695 - Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof (2020-08-04),

6. 10639306 - Aldose reductase inhibitors and uses thereof (2020-05-05),

7. 10265320 - Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof (2019-04-23),

8. 10052324 - Aldose reductase inhibitors and uses thereof (2018-08-21),

9. 9650383 - Aldose reductase inhibitors and uses thereof (2017-05-16),

10. 9364472 - Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof (2016-06-14),

11. 9353078 - Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof (2016-05-31),

12. 8133866 - Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury (2012-03-13),

13. 8124829 - Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof (2012-02-28),

14. 8067371 - RAGE G82S-related methods and compositions for treating inflammatory disorders (2011-11-29),

15. 7919670 - Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof (2011-04-05),

Title: The Innovative Journey of Ann Marie Schmidt

Introduction: Ann Marie Schmidt, a pioneering inventor hailing from Franklin Lakes, NJ (US), has made significant contributions to the world of innovations with her groundbreaking ideas and inventions.

Latest Patents: Ann Marie Schmidt holds several patents in various fields, including technology, healthcare, and consumer products. Her most recent patent involves a cutting-edge medical device designed to revolutionize surgical procedures.

Career Highlights: Throughout her illustrious career, Ann Marie Schmidt has consistently demonstrated her passion for innovation and problem-solving. Her inventions have not only improved existing technologies but have also opened new avenues for future developments in the industry.

Collaborations: Ann Marie Schmidt has collaborated with leading research institutions, universities, and companies to bring her inventions to life. Her ability to work effectively in multidisciplinary teams has been instrumental in the success of her projects.

Conclusion: Ann Marie Schmidt's dedication to innovation and her relentless pursuit of excellence have established her as a prominent figure in the world of inventors. Her remarkable achievements continue to inspire aspiring inventors and pave the way for a future filled with groundbreaking discoveries.